RhythmAnalytics vs Cleerly LABS

Cleerly LABS (Tool B) offers a web-based application with interactive 3D visualization of coronary arteries, providing a rich diagnostic user experience for clinicians to review and interpret results directly. RhythmAnalytics (Tool A), while cloud-based, is primarily offered as an API for integration into existing systems, suggesting a more technical or indirect user experience.

Both tools offer significant clinical value in distinct areas of cardiology. However, Cleerly LABS (Tool B) provides a more comprehensive and potentially transformative approach by not only detecting stenosis but also quantifying and characterizing coronary plaque and identifying ischemia from CCTA, which is crucial for personalized heart disease management and prevention. RhythmAnalytics (Tool A) focuses on automated interpretation of cardiac arrhythmias from ECG data, which, while valuable, addresses a different clinical need.

Cleerly LABS (Tool B) offers transparent pricing per analysis and, more importantly, has secured significant insurance coverage from major payers like UnitedHealthcare, Cigna, and Aetna, as well as Medicare, greatly enhancing its accessibility and value for patients and providers. RhythmAnalytics (Tool A) lacks public pricing details, requiring direct vendor contact, which makes its value proposition less clear.

Cleerly LABS (Tool B) explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA), along with a robust cloud-based (AWS) deployment model that includes an on-site proxy for secure data transfer and integration with PACS, RIS, and EHR. RhythmAnalytics (Tool A) is HIPAA compliant and FDA cleared, but its BAA status is unspecified, which is a critical factor for enterprise adoption in healthcare.

Cleerly LABS (Tool B) demonstrates higher innovation by moving beyond traditional stenosis assessment to offer comprehensive coronary plaque characterization (volume, type) and ischemia detection from CCTA, aiming to redefine heart disease diagnosis and prevention. While RhythmAnalytics (Tool A) uses advanced AI for ECG interpretation, the detailed plaque analysis and personalized risk assessment offered by Tool B represent a more novel and impactful shift in cardiovascular care.

Cleerly LABS (Tool B) provides clear information regarding its support availability, stating that support is available Monday through Friday during business hours with after-hours needs addressed as a first priority. It also emphasizes a team dedicated to timely answers and efficient problem-solving. RhythmAnalytics (Tool A) does not provide specific public details about its support services or documentation.